Skip to main content

Rigel Pharmaceuticals Inc

RIGL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001034842

No open-market purchases or sales by Rigel Pharmaceuticals Inc insiders were filed in the last 90 days; 155 institutions reported holding it in 13F filings for Q2 2026, worth $640.4M in total; no superinvestor holds it.

13F holders, Q3 2022

Institutional positions in Rigel Pharmaceuticals Inc as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
138
+3 vs. Q2 2022
Shares held
127.9M
−11.3M (−8.1%) vs. Q2 2022
Total value
$150.3M
−$6.91M (−4.4%) vs. Q2 2022
New holders
21
44 more added
Sold out
18
35 more reduced

Compare with Q2 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting RIGL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2022: 138 institutions
Q1 2021: 152 institutionsQ2 2021: 160 institutionsQ3 2021: 163 institutionsQ4 2021: 162 institutionsQ1 2022: 163 institutionsQ2 2022: 135 institutionsQ3 2022: 138 institutionsQ4 2022: 118 institutionsQ1 2023: 125 institutionsQ2 2023: 118 institutionsQ3 2023: 106 institutionsQ4 2023: 113 institutionsQ1 2024: 117 institutionsQ2 2024: 91 institutionsQ3 2024: 93 institutionsQ4 2024: 122 institutionsQ1 2025: 123 institutionsQ2 2025: 126 institutionsQ3 2025: 169 institutionsQ4 2025: 194 institutionsQ1 2026: 159 institutionsQ2 2026: 155 institutions
Value heldQ3 2022: $150.3M
Q1 2021: $493.1MQ2 2021: $614.5MQ3 2021: $499.6MQ4 2021: $365.9MQ1 2022: $405.7MQ2 2022: $157.2MQ3 2022: $150.3MQ4 2022: $163.1MQ1 2023: $148.6MQ2 2023: $142.7MQ3 2023: $114.8MQ4 2023: $154.5MQ1 2024: $164.3MQ2 2024: $85.4MQ3 2024: $192.6MQ4 2024: $203.0MQ1 2025: $250.2MQ2 2025: $260.2MQ3 2025: $425.6MQ4 2025: $690.5MQ1 2026: $432.8MQ2 2026: $640.4M
Institutions holding RIGL and their total value by quarter
QuarterHoldersValue
Q2 2026155$640.4M
Q1 2026159$432.8M
Q4 2025194$690.5M
Q3 2025169$425.6M
Q2 2025126$260.2M
Q1 2025123$250.2M
Q4 2024122$203.0M
Q3 202493$192.6M
Q2 202491$85.4M
Q1 2024117$164.3M
Q4 2023113$154.5M
Q3 2023106$114.8M
Q2 2023118$142.7M
Q1 2023125$148.6M
Q4 2022118$163.1M
Q3 2022138$150.3M
Q2 2022135$157.2M
Q1 2022163$405.7M
Q4 2021162$365.9M
Q3 2021163$499.6M
Q2 2021160$614.5M
Q1 2021152$493.1M

Institutions, Q3 2022

Shares, value and share of portfolio for each institution holding Rigel Pharmaceuticals Inc; share changes are against Q2 2022.

Institutions holding RIGL in Q3 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Squarepoint Ops LLC566,815$669.0K0.01%+566,815New
Bank of New York Mellon Corp568,712$671.0K0.00%+45,103+8.6%Added
Qube Research & Technologies Ltd576,606$680.0K0.00%+576,606New
Panagora Asset Management Inc634,686$749.0K0.01%+104,455+19.7%Added
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main738,260$871.1K0.00%+738,260New
Rhenman & Partners Asset Management AB1,225,081$893.0K0.09%00.0%Unchanged
Charles Schwab Investment Management Inc869,594$1.03M0.00%+2,244+0.3%Added
Morgan Stanley902,570$1.06M0.00%−1,286,408−58.8%Reduced
Graham Capital Management, L.P.935,294$1.10M0.05%+813,642+668.8%Added
HRT Financial LP1,083,635$1.28M0.01%+1,083,635New
CM Management, LLC1,300,000$1.53M1.71%00.0%Unchanged
Renaissance Technologies LLC1,305,226$1.54M0.00%+940,726+258.1%Added
Sector Gamma AS1,346,904$1.59M0.41%−119,774−8.2%Reduced
Two Sigma Investments, LP1,532,861$1.81M0.01%+911,298+146.6%Added
Wellington Management Group LLP1,550,204$1.83M0.00%−110,198−6.6%Reduced
Macquarie Group Ltd1,600,000$1.89M0.00%−3,252−0.2%Reduced
Northern Trust Corp1,615,678$1.91M0.00%−29,551−1.8%Reduced
Two Sigma Advisers, LP1,948,291$2.30M0.01%+1,632,700+517.3%Added
Tamarack Advisers, LP2,000,000$2.36M1.39%00.0%Unchanged
Sphera Funds Management Ltd.2,162,586$2.55M0.45%−362,414−14.4%Reduced
Acadian Asset Management LLC2,191,861$2.58M0.01%−26,412−1.2%Reduced
Nuveen Asset Management, LLC2,257,471$2.66M0.00%−838,171−27.1%Reduced
Goldman Sachs Group Inc2,423,908$2.86M0.00%+485,984+25.1%Added
Assenagon Asset Management S.A.2,679,850$3.16M0.01%+1,020,104+61.5%Added
Jacobs Levy Equity Management, Inc2,960,001$3.49M0.03%+2,960,001New
Geode Capital Management, LLC3,086,408$3.64M0.00%+17,949+0.6%Added
Hudson Bay Capital Management LP3,300,000$3.89M0.04%−700,000−17.5%Reduced
Armistice Capital, LLC3,452,874$4.07M0.10%+3,452,874New
Voya Investment Management LLC3,597,586$4.25M0.01%+3,485,036+3,096.4%Added
State Street Corp3,878,066$4.58M0.00%−20,067,502−83.8%Reduced
Citadel Advisors LLC4,583,348$5.41M0.01%+685,864+17.6%Added
D. E. Shaw & Co., Inc.4,646,464$5.48M0.01%+1,171,928+33.7%Added
Invesco Ltd.5,168,413$6.10M0.00%+8,547+0.2%Added
Millennium Management LLC7,202,938$8.50M0.01%+6,576,296+1,049.5%Added
Vanguard Group Inc11,942,196$14.1M0.00%+1,463,026+14.0%Added
FMR LLC15,486,587$18.3M0.00%−8,640,483−35.8%Reduced
BlackRock Inc.16,180,237$19.1M0.00%−247,484−1.5%Reduced
IFP Advisors, Inc2,027––00.0%Unchanged
Candriam Luxembourg S.C.A.0$00.00%−1,429,630−100.0%Sold out
Rafferty Asset Management, LLC0$00.00%−1,088,543−100.0%Sold out
Woodline Partners LP0$00.00%−861,305−100.0%Sold out
Ikarian Capital, LLC0$00.00%−702,773−100.0%Sold out
Adage Capital Partners GP, L.L.C.0$00.00%−700,000−100.0%Sold out
UBS Group AG0$00.00%−590,858−100.0%Sold out
DAFNA Capital Management LLC0$00.00%−390,066−100.0%Sold out
Caption Management, LLC0$00.00%−345,300−100.0%Sold out
Dimensional Fund Advisors LP0$00.00%−287,685−100.0%Sold out
Virtu Financial LLC0$00.00%−245,227−100.0%Sold out
First Hawaiian Bank0$00.00%−163,484−100.0%Sold out
E Fund Management Co., Ltd.0$00.00%−124,818−100.0%Sold out
Boothbay Fund Management, LLC0$00.00%−96,883−100.0%Sold out
Oppenheimer & Co Inc0$00.00%−42,587−100.0%Sold out
Two Sigma Securities, LLC0$00.00%−36,466−100.0%Sold out
State of Wyoming0$00.00%−7,975−100.0%Sold out
Captrust Financial Advisors0$00.00%−1,084−100.0%Sold out
Aquatic Capital Management LLC0$00.00%−1,200−100.0%Sold out